awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39118597-844B2D44-0EB6-43E7-A595-0197A7559903
Q39118597-844B2D44-0EB6-43E7-A595-0197A7559903
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39118597-844B2D44-0EB6-43E7-A595-0197A7559903
Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits non-small cell lung cancer
P2860
Q39118597-844B2D44-0EB6-43E7-A595-0197A7559903
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39118597-844B2D44-0EB6-43E7-A595-0197A7559903
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a149f7df67239d8142f5141a10d0da41c258cedf
P2860
Afatinib: emerging next-generation tyrosine kinase inhibitor for NSCLC.